Key result
Off-label Aviator Plus balloon dilation shows 100% immediate gradient reduction in infant left heart obstruction.
Why the study?
Experience with high-pressure, rapid-exchange balloon systems such as the Aviator Plus for dilating left heart obstructive lesions in infants remains limited.
Does off-label balloon dilation using the Aviator Plus platform provide feasible gradient reduction in infants with left heart obstruction?
Observational (n=4)
No
Does off-label balloon dilation using the Aviator Plus platform provide feasible gradient reduction in infants with left heart obstruction?
Off-label use of the Aviator Plus balloon achieved immediate gradient reduction in a small series of infants with left heart obstruction, demonstrating early feasibility.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Supports early feasibility of off-label Aviator Plus dilation in infant left heart obstruction; leaves open long-term durability pending larger trials.
Background Balloon dilation is an established option for selected left heart obstructive lesions in infants, traditionally using low-profile, low-pressure balloons. Experience with high-pressure, rapid-exchange systems such as the Aviator Plus in this age group remains limited. Objective To describe feasibility, procedural performance, and early outcomes of off-label balloon dilation using the Aviator Plus platform in infants with coarctation of the aorta or valvular aortic stenosis. Methods A retrospective review was performed of infants undergoing Aviator Plus balloon dilation between April 2024 and July 2025. Clinical features, procedural details, and follow-up outcomes were summarized descriptively. Results Four infants (mean age 5.5 months; mean weight 5.87 kg) underwent intervention: three with native coarctation of the aorta and one with severe aortic stenosis. One coarctation of the aorta patient had significant left ventricular dysfunction; the aortic stenosis patient had moderate mitral regurgitation. Balloon dilation used a single 6 × 20 mm balloon in two cases and sequential 6 × 20 mm and 7 × 20 mm balloons in two. All procedures produced immediate gradient reduction. During a mean 8.5-month follow-up, one infant with aortic stenosis died from progression of mitral regurgitation and intercurrent infection, and one coarctation of the aorta patient required surgical repair for re-coarctation. The remaining infants maintained gradient relief with preserved ventricular function. Conclusions This early experience suggests that the Aviator Plus balloon can be a feasible off-label option for carefully selected infants with left heart obstruction, particularly where pediatric-specific balloons are limited. Larger series with extended follow-up are needed to define long-term outcomes.
Singhi et al. (2026) conducted an observational in Left heart obstruction (coarctation of the aorta or valvular aortic stenosis) (n=4). Aviator Plus balloon dilation was evaluated on Immediate gradient reduction. Off-label balloon dilation using the Aviator Plus platform produced immediate gradient reduction in all 4 infants with left heart obstruction, though 2 experienced adverse events during follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: